Clinical role of calprotectin assay in determining histological relapses in children affected by inflammatory bowel diseases.

@article{Diamanti2008ClinicalRO,
  title={Clinical role of calprotectin assay in determining histological relapses in children affected by inflammatory bowel diseases.},
  author={Antonella Diamanti and Franco Colistro and Maria Sole Basso and Bronislava Papadatou and Paola Francalanci and Fiammetta Bracci and Monica Muraca and Daniela Knafelz and Paola de Angelis and Massimo Castro},
  journal={Inflammatory bowel diseases},
  year={2008},
  volume={14 9},
  pages={
          1229-35
        }
}
BACKGROUND Inflammatory bowel diseases (IBD) are characterized by periods of remission with recurrent episodes of symptom exacerbation because of acute intestinal inflammation, which is correctly evaluated by endoscopy with biopsy sampling. However, many surrogate markers of intestinal inflammation, including fecal calprotectin (FC), are detected as potential predictors of mucosal inflammation in IBD patients. The aim of our study was to retrospectively assess the clinical efficacy of the… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 1 time over the past 90 days. VIEW TWEETS

Citations

Publications citing this paper.
Showing 1-10 of 32 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 25 references

Combined use of noninvasive test is useful in the initial diagnostic approach to a child with suspected inflammatory bowel disease

  • R Berni Canani, L Tanturri de Horatio, G Terrin
  • J Pediatr Gastroenterol Nutr
  • 2006

Diagnostic value of faecal calprotectin in paediatric gastroenterology clinical practice

  • R Berni Canani, L Rapacciuolo, MT Romano
  • Dig Liver Dis
  • 2004

Similar Papers

Loading similar papers…